6.78
price up icon5.44%   0.35
pre-market  Pre-market:  6.81   0.03   +0.44%
loading
Optimizerx Corp stock is traded at $6.78, with a volume of 733.10K. It is up +5.44% in the last 24 hours and down -11.26% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
See More
Previous Close:
$6.43
Open:
$6.37
24h Volume:
733.10K
Relative Volume:
1.87
Market Cap:
$127.21M
Revenue:
$109.43M
Net Income/Loss:
$5.13M
P/E Ratio:
26.02
EPS:
0.2606
Net Cash Flow:
$18.91M
1W Performance:
+2.42%
1M Performance:
-11.26%
6M Performance:
-63.17%
1Y Performance:
-24.67%
1-Day Range:
Value
$6.29
$6.86
1-Week Range:
Value
$5.94
$6.86
52-Week Range:
Value
$5.54
$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name
Name
Optimizerx Corp
Name
Phone
248-651-6558
Name
Address
260 CHARLES STREET, WALTHAM, MI
Name
Employee
105
Name
Twitter
@OpRxTweets
Name
Next Earnings Date
2025-03-12
Name
Latest SEC Filings
Name
OPRX's Discussions on Twitter

Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
OPRX icon
OPRX
Optimizerx Corp
6.78 127.21M 109.43M 5.13M 18.91M 0.2606
VEEV icon
VEEV
Veeva Systems Inc
179.11 29.44B 3.20B 908.91M 1.39B 5.4168
TEM icon
TEM
Tempus Ai Inc
48.83 8.73B 1.27B -245.03M -245.36M -1.4071
BTSG icon
BTSG
Brightspring Health Services Inc
43.31 8.32B 12.91B 104.80M 394.69M 0.8769
HQY icon
HQY
Healthequity Inc
82.10 6.94B 1.31B 215.20M 408.32M 2.4627
WAY icon
WAY
Waystar Holding Corp
24.03 4.61B 1.10B 112.09M 283.19M 0.6096

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Dec-20-24 Initiated Stephens Equal-Weight
Jul-25-24 Resumed B. Riley Securities Buy
Apr-04-24 Initiated JMP Securities Mkt Outperform
Jan-03-24 Initiated Barclays Equal Weight
Feb-02-23 Resumed B. Riley Securities Buy
Nov-01-22 Initiated Stifel Buy
Jul-15-22 Initiated SVB Leerink Outperform
Oct-18-21 Resumed B. Riley Securities Buy
Apr-13-21 Initiated RBC Capital Mkts Outperform
Jan-03-19 Initiated William Blair Outperform
View All

Optimizerx Corp Stock (OPRX) Latest News

pulisher
Mar 24, 2026

If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan

Mar 24, 2026
pulisher
Mar 24, 2026

Best Value Stocks to Buy for March 24th - sharewise.com

Mar 24, 2026
pulisher
Mar 23, 2026

OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN

Mar 23, 2026
pulisher
Mar 20, 2026

Strength seen in OptimizeRx (OPRX): Can its 7.5% jump turn into more strength? - MSN

Mar 20, 2026
pulisher
Mar 20, 2026

Guidance Update: Can OptimizeRx Corporation sustain earnings growthEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 20, 2026

OPRX Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 20, 2026
pulisher
Mar 19, 2026

How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice - Yahoo Finance

Mar 19, 2026
pulisher
Mar 16, 2026

OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance

Mar 16, 2026
pulisher
Mar 16, 2026

Best Value Stocks to Buy for March 16th - The Globe and Mail

Mar 16, 2026
pulisher
Mar 15, 2026

Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - MSN

Mar 15, 2026
pulisher
Mar 14, 2026

OptimizeRx Corp. (OPRX) Q4 earnings and revenues beat estimates - MSN

Mar 14, 2026
pulisher
Mar 12, 2026

OptimizeRx (OPRX) outlines AI-driven pharma marketing strategy and key risks - Stock Titan

Mar 12, 2026
pulisher
Mar 10, 2026

Should you sell your OptimizeRx stock? - Cantech Letter

Mar 10, 2026
pulisher
Mar 10, 2026

OptimizeRx Corporation Common Stock OPRX ) Stock Price Today & Analysis - Gotrade

Mar 10, 2026
pulisher
Mar 07, 2026

OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 07, 2026
pulisher
Mar 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Mar 07, 2026
pulisher
Mar 06, 2026

OptimizeRx (OPRX) Q4 Profitability Turn Challenges Skeptical Earnings Narratives - simplywall.st

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Bitget

Mar 06, 2026
pulisher
Mar 06, 2026

Assessing OptimizeRx: Insights From 4 Financial Analysts - Benzinga

Mar 06, 2026
pulisher
Mar 06, 2026

B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx (OPRX) Target Price Lowered by Stephens & Co. | OPRX Stock News - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00 - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Stephens cuts OptimizeRx stock price target on soft pharma budgets - Investing.com Nigeria

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx Corporation Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript - AOL.com

Mar 06, 2026
pulisher
Mar 06, 2026

Stephens cuts OptimizeRx stock price target on soft pharma budgets By Investing.com - Investing.com UK

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Mar 06, 2026
pulisher
Mar 06, 2026

UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail

Mar 06, 2026
pulisher
Mar 06, 2026

OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Mar 06, 2026
pulisher
Mar 05, 2026

OptimizeRx Q4 Earnings Call Highlights - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Stock Repurchase Plan Initiated by OptimizeRx (NASDAQ:OPRX) Board of Directors - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

From loss to profit: OptimizeRx posts record $109.4M sales and $10M buyback - Stock Titan

Mar 05, 2026
pulisher
Mar 05, 2026

Earnings call transcript: OptimizeRx Q4 2025 earnings beat expectations amid cautious market - Investing.com

Mar 05, 2026
pulisher
Mar 05, 2026

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

OPTIMIZERx earnings beat by $0.29, revenue topped estimates - Investing.com Canada

Mar 05, 2026
pulisher
Mar 05, 2026

UPDATEOptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Mar 05, 2026
pulisher
Mar 05, 2026

Optimizerx Corp enters amendment no. 4 to financing agreementSEC filing - marketscreener.com

Mar 05, 2026
pulisher
Mar 05, 2026

OptimizeRx Reports Strong Q4 2025 Results with Record Net Income and Adjusted EBITDA, Updates 2026 Revenue Guidance and Announces Share Repurchase Program - Quiver Quantitative

Mar 05, 2026
pulisher
Mar 05, 2026

Optimizerx Corp Enters Amendment No. 4 To Financing Agreement- SEC Filing - TradingView

Mar 05, 2026
pulisher
Mar 05, 2026

OptimizeRx Q4 Adjusted Earnings Rise; Reports Buyback Program - marketscreener.com

Mar 05, 2026
pulisher
Mar 05, 2026

Geopolitics Watch: Can OptimizeRx Corporation sustain earnings growthTrade Performance Summary & Smart Money Movement Tracker - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 05, 2026

OptimizeRx Corporation (OPRX) Stock Rises on Q4 2025 Earnings - Quiver Quantitative

Mar 05, 2026
pulisher
Mar 05, 2026

OptimizeRx Authorizes $10 Million Share Repurchase Program - TipRanks

Mar 05, 2026
pulisher
Mar 05, 2026

OptimizeRx (Nasdaq: OPRX) returns to profit and unveils $10M share repurchase plan - Stock Titan

Mar 05, 2026
pulisher
Mar 05, 2026

OptimizeRx Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Mar 05, 2026
pulisher
Mar 04, 2026

OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 P.m. ET - 富途牛牛

Mar 04, 2026
pulisher
Mar 04, 2026

Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q4 2025 Result - GuruFocus

Mar 04, 2026

Optimizerx Corp Stock (OPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
TXG TXG
$19.81
price up icon 3.50%
$21.03
price down icon 2.28%
$40.91
price down icon 2.85%
$24.34
price down icon 2.76%
$16.31
price down icon 4.62%
WAY WAY
$24.03
price down icon 2.40%
Cap:     |  Volume (24h):